About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Pittsburgh | 10,712 Studies Near You

Clinical TrialsPittsburgh

Clinical Trials in Pittsburgh

Discover 10,712 clinical trials near Pittsburgh, Pennsylvania. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5881-5900 of 10,712 trials

CompletedEvaluating FDA's Proposed Patient Medication Information HandoutThe goal of this study is to assess how useful the proposed one-page FDA-template PMI is to potential users.NCT06320808·Pittsburgh, Pennsylvania RecruitingEfficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental OxygenThe purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental oxygen, on the prevention of…NCT05624450·Birmingham, Alabama and 470 others

Find Trials by Condition in Pittsburgh

Breast Cancerin Pittsburgh Lung Cancerin Pittsburgh Prostate Cancerin Pittsburgh Colorectal Cancerin Pittsburgh Melanomain Pittsburgh Leukemiain Pittsburgh Lymphomain Pittsburgh Pancreatic Cancerin Pittsburgh Ovarian Cancerin Pittsburgh Brain Cancerin Pittsburgh

Data from ClinicalTrials.govTerms

CompletedStudy of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic MelanomaProspective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin 2 (IL-2) after a…NCT02360579·La Jolla, California and 56 others

CompletedA Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)This randomized, multicenter, double-blind, placebo-controlled study will evaluate the efficacy and safety of onartuzumab (MetMAb) in combination with Tarceva (erlotinib) in…NCT01456325·Chandler, Arizona and 212 others

CompletedStudy of GemOx and Vandetanib in Advanced Solid MalignancyThis is a research study that will try to find the highest and safest dose of an experimental drug, vandetanib, that can be given in combination with two standard chemotherapy…NCT00660725·Pittsburgh, Pennsylvania

CompletedPharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast CancerThis study will examine the inhibition of ErbB1 and ErbB2 phosphorylation and downstream mediators of tumor cell growth and survival tumor tissue in treatment-naive breast cancer…NCT00359190·Miami, Florida and 9 others

CompletedChemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's DiseaseThis randomized phase III trial is studying different chemotherapy regimens given with or without radiation therapy to compare how well they work in treating children with newly…NCT00025259·Birmingham, Alabama and 174 others

TerminatedPemetrexed and LBH589 in Patients With Advanced Non-Small Cell Lung CancerLBH589 is a drug that may slow down the growth of cancer cells or kill cancer cells by blocking certain enzymes.NCT00907179·Pittsburgh, Pennsylvania

CompletedRED-HF™ Trial - Reduction of Events With Darbepoetin Alfa in Heart Failure TrialThe purpose of the study is to determine the efficacy of treatment of anemia with darbepoetin alfa compared to placebo on the composite of time to death from any cause or first…NCT00358215·Birmingham, Alabama and 753 others

RecruitingREdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuREThe purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).NCT06777368·Birmingham, Alabama and 70 others

CompletedAttention Bias Modification for Transdiagnostic AnxietyThis project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of…NCT02303691·Pittsburgh, Pennsylvania

CompletedA Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic RhinitisThe purpose of this study is to determine if one allergy treatment (0.15% azelastine hydrochloride) is as safe as mometasone furoate (nasonex) alone.NCT00720382·Oxford, Alabama and 58 others

RecruitingZanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsThe primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or…NCT06943755·Birmingham, Alabama and 130 others

TerminatedStudy of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate CancerBone metastases and associated pain are a major cause of morbidity and mortality in castration-resistant prostate cancer (CRPC).NCT01522443·Scottsdale, Arizona and 81 others

WithdrawnEvaluation of Tolsura When Used as Prophylaxis After Lung TransplantationThis is a single-center, observational study of Tolsura PK sampling in lung transplant recipientsNCT04652050·Pittsburgh, Pennsylvania

CompletedSafety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (MIRA-3)The objectives of this study are: * To evaluate the efficacy of Nyxol to expedite the reversal of pharmacologically-induced mydriasis across multiple mydriatic agents with an…NCT05134974·Newport Beach, California and 14 others

CompletedPharmacokinetic Profile of Inhaled Liposomal Amphotericin B in Lung Transplant Recipients - Ambisome StudyThe purpose of this study is to determine the steady state concentrations of inhaled liposomal amphotericin B (Ambisome®) in lung transplant recipients via aerosolized…NCT00177710·Pittsburgh, Pennsylvania

CompletedSelective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHDThis phase II trial is for patients with acute lymphocytic leukemia, acute myeloid leukemia, myelodysplastic syndrome or chronic myeloid leukemia who have been referred for a…NCT02220985·Pittsburgh, Pennsylvania and 1 other

CompletedA Phase 2 Study of Pembrolizumab (MK-3475) in Combination With Azacitidine in Subjects With Chemo-refractory Metastatic Colorectal CancerThis is an open label, single-arm, Phase 2 trial to evaluate the anti-tumor activity, safety, and tolerability of Pembrolizumab in combination with azacitidine in subjects with…NCT02260440·Pittsburgh, Pennsylvania

RecruitingA Research Study to Advance the CF Therapeutics Pipeline for People Without ModulatorsThe REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators.NCT06504589·Birmingham, Alabama and 67 others

PreviousPage 295 of 536Next

Diabetes

in Pittsburgh

Heart Diseasein Pittsburgh